Pulmonary aspergillosis in an unselected hospital population.
D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D000906:Antibodies; D001228:Aspergillosis / Q000188:drug therapy; D001230:Aspergillus / Q000302:isolation & purification; D001982:Bronchial Diseases / Q000188:drug therapy; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005260:Female; D006636:Histamine Release; D006801:Humans; D007073:Immunoglobulin E; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010866:Natamycin / Q000627:therapeutic use; D011233:Precipitin Tests; D012130:Respiratory Hypersensitivity / Q000209:etiology; D012882:Skin Tests; D013183:Sputum / Q000382:microbiology
D000906:Antibodies; D007073:Immunoglobulin E; D000666:Amphotericin B; D010866:Natamycin; D004205:Cromolyn Sodium